• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

15.94 -0.45 (-2.75%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 906,005
Open 16.38
Bid (Size) 15.70 (500)
Ask (Size) 16.50 (100)
Prev. Close 16.39
Today's Range 15.89 - 16.39
52wk Range 5.940 - 16.92
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Stocks Under $50 with Open Questions
August 06, 2026
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However... 
Via StockStory
News headline image
3 Healthcare Stocks with Questionable Fundamentals
August 03, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on... 
Via StockStory

Performance

YTD
+35.5%
+35.5%
1 Month
+7.4%
+7.4%
3 Month
+90.4%
+90.4%
6 Month
+39.3%
+39.3%
1 Year
+156.7%
+156.7%

More News

Read More
News headline image
Why NeoGenomics (NEO) Stock Is Up Today
July 29, 2026
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
July 29, 2026
Via StockStory
NeoGenomics (NASDAQ:NEO): Quality Stock After Q2 Earnings Beat and Raised Guidance ↗
July 28, 2026
Via Chartmill
Topics Earnings
News headline image
NeoGenomics Q2 Earnings Call Highlights ↗
July 28, 2026
Via MarketBeat
Topics Earnings
News headline image
NeoGenomics’s (NASDAQ:NEO) Q2 CY2026: Beats On Revenue
July 28, 2026
Via StockStory
News headline image
NeoGenomics Reports Second Quarter 2026 Results
July 28, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics (NEO) Q2 Earnings Report Preview: What To Look For
July 26, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
1 Momentum Stock with Solid Fundamentals and 2 We Avoid
July 23, 2026
Via StockStory
News headline image
NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS
July 20, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
3 Small-Cap Stocks with Questionable Fundamentals
July 15, 2026
Via StockStory
News headline image
NeoGenomics (NEO) Stock Trades Up, Here Is Why
July 09, 2026
Via StockStory
Topics Intellectual Property Lawsuit
News headline image
NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
July 09, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026
July 07, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
A Look Back at Testing & Diagnostics Services Stocks’ Q1 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack
June 25, 2026
Via StockStory
News headline image
NeoGenomics Appoints Carolyn Starrett to its Board of Directors
June 25, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
1 Unprofitable Stock for Long-Term Investors and 2 Facing Headwinds
June 19, 2026
Via StockStory
News headline image
NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes
June 17, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes
June 15, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present New Research at ASCO Annual Meeting 2026
May 26, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Participate in Upcoming Investor Conferences
May 15, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know
May 13, 2026
Via StockStory
Topics Economy
News headline image
3 Russell 2000 Stocks We’re Skeptical Of
May 08, 2026
Via StockStory
News headline image
3 Reasons NEO is Risky and 1 Stock to Buy Instead
May 06, 2026
Via StockStory
Topics Bankruptcy Stocks Supply Chain

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?
Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
What exchange does NeoGenomics, Inc. - Common Stock trade on?
NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
What is the current price of NeoGenomics, Inc. - Common Stock?
The current price of NeoGenomics, Inc. - Common Stock is 15.94
When was NeoGenomics, Inc. - Common Stock last traded?
The last trade of NeoGenomics, Inc. - Common Stock was at 08/14/26 04:00 PM ET
What is the market capitalization of NeoGenomics, Inc. - Common Stock?
The market capitalization of NeoGenomics, Inc. - Common Stock is 1.96B
How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
NeoGenomics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap